Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader is advising Integrity Implants Inc. (d/b/a Accelus) in its definitive business combination agreement with CHP Merger Corporation (NASDAQ: CHPM), a special acquisition company (SPAC), in a transaction with an implied enterprise value of approximately $482 million. https://www.cadwalader.com/news/news-release/cadwalader-advises-accelus-on-482-million-combination-with-chp-merger-corporation